Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection

Science Advances(2025)10.1126/sciadv.adw0659Source: DataRank Database

The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection is a research paper published in Science Advances (2025). On theSindex it has a DataRank of 0.483. It has been cited 19 times, with 14 citing works in its 1-hop citation network.

N/A

0.483DataRank · unranked

Scored on demand from live citation data

19 citations · 14 citing works in its network

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 14.05)OA: goldTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 93%Citation Network 7%

Base Score Contribution

0.449

From this paper's citation signal

Citation Network Contribution

0.0333

From 3 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 14 citers.

Evaluation of Probenecid Against Filovirus Replication in Vero E6 Cells
Viruses20251 citations21 referencesContributes 0.033
Potential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever Viruses
Arteriosclerosis Thrombosis and Vascular Biology20251 citations199 referencesContributes 0.003
Impact of emerging and re-emerging viral infections on periodontitis progression
Archives of Microbiology20251 citations256 referencesContributes 0.003
Viral hemorrhagic fevers - therapeutic trial advances and challenges
Expert Review of Anti-infective Therapy20250 citations123 referencesContributes 0.000
SARS-CoV-2 resistance analyses from the Phase 3 OAKTREE study of obeldesivir in low-risk nonhospitalized participants with COVID-19
Antiviral Research20250 citations33 referencesContributes 0.000

Authors (17)

Robert W. Cross ORCID,Victor C. Chu ORCID,Abhishek N. Prasad ORCID,Krystle N. Agans ORCID,Viktoriya Borisevich

Live enrichment

PubMed:40085692 PMC:PMC11908469 OpenAlex:https://openalex.org/W4408423747

NIAID NIH HHS

Grant: U19 AI142785

National Institutes of Health

Grant: 1U19AI142785-01

Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections

National Institutes of Health

Grant: 5UC7AI094660-03

National Biocontainment Laboratories (NBLs) Operations Support

FWCI

14.05

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.science.org/doi/pdf/10.1126/sciadv.adw0659?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.adw0659?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.adw0659

journalhttps://doi.org/10.1126/sciadv.adw0659

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40085692

Fields of Study

Viral Infections and Outbreaks ResearchCOVID-19 epidemiological studiesViral Infections and Vectors0301 basic medicine03 medical and health sciencesAnimalsHemorrhagic Fever, EbolaEbolavirusAdministration, OralAntiviral AgentsMacaca fascicularisMacaca mulattaVirus ReplicationDisease Models, Animal

MeSH Terms

Administration, OralAnimalsAntiviral AgentsDisease Models, AnimalHumansMacaca fascicularisMacaca mulattaVirus ReplicationHemorrhagic Fever, EbolaEbolavirus

Keywords

Ebola virusVirologyBroad spectrumVirusProdrugOral administrationDrugPharmacologyMedicineImmunityImmunologyAntiviral drugOutbreakBiologyImmune systemChemistryMacaca fascicularisDisease Models, AnimalAnimalsAdministration, OralBiomedicine and Life SciencesHemorrhagic Fever, EbolaEbolavirusVirus ReplicationAntiviral AgentsMacaca mulatta

Sustainable Development Goals

SDG 0: Good health and well-being

The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (17)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)